(Q64350376)
Statements
A Phase 3b, Multicenter, Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia Who Have Previously Participated in a Trial of Titrated Oral SAMSCA® (Tolvaptan) (English)
0 references
April 2016
0 references
23 October 2017
0 references
3
0 references
4 year
0 references
18 year
0 references